Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. J Clin Oncol. 2010 Nov 01; 28(31):4674-82.

View in: PubMed

subject areas

Aged
Aged, 80 and over
Androstadienes
Antineoplastic Agents
Aromatase Inhibitors
Breast Neoplasms
Case-Control Studies
Chromosome Mapping
Chromosomes, Human, Pair 14
Clinical Trials, Phase III as Topic
Estrogens
Female
Gene Expression Regulation, Neoplastic
Genome-Wide Association Study
Genotype
Humans
Logistic Models
Middle Aged
Musculoskeletal System
Neoplasm Staging
Nitriles
Polymorphism, Single Nucleotide
Postmenopause
Proto-Oncogene Proteins
Randomized Controlled Trials as Topic
Receptors, Interleukin-17
Retrospective Studies
Severity of Illness Index
Triazoles

authors with profiles

Yusuke Nakamura